Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Health GroupHKSE:08225 Current Ratio is 2.46 as of Dec. 2025, which is 10% below its 10-year median of 2.72. The stock has 4 warning signs investors should review. Among 212 Medical Diagnostics & Research companies, China Health Group ranks better than 57.08% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. China Health Group's current ratio for the quarter that ended in Dec. 2025 was 2.46.
China Health Group has a current ratio of 2.46. It generally indicates good short-term financial strength.
The historical rank and industry rank for China Health Group's Current Ratio or its related term are showing as below:
HKSE:08225'
s Current Ratio Range Over the Past 10 Years
Min: 0.24 Med: 2.72 Max: 4.97
Current: 2.46
During the past 13 years, China Health Group's highest Current Ratio was 4.97. The lowest was 0.24. And the median was 2.72.
HKSE:08225's Current Ratio is ranked better than 57.08% of 212
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.13
vs HKSE:08225: 2.46
China Health Group (HKSE:08225) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
China Health Group Current Ratio Related Terms
China Health Group Current Ratio Historical Data
* Premium members only.
The historical data trend for China Health Group's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:08225 vs TMO, DHR, IDXX: Current Ratio Comparison
For the Diagnostics & Research subindustry, China Health Group's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Health Group Current Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, China Health Group's Current Ratio distribution charts can be found below:
* The bar in red indicates where China Health Group's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Group (HKSE:08225) has a Current Ratio of 2.46 as of Dec. 2025. This is 10% below median its historical median of 2.72. Over the past decade, China Health Group's Current Ratio has ranged from 0.24 to 4.97. According to the industry distribution chart, China Health Group ranks #91 out of 212 companies in the Medical Diagnostics & Research industry, placing it in the top 42.9%.
Is China Health Group's Current Ratio too high?
China Health Group's current Current Ratio of 2.46 is 10% below median its 10-year median of 2.72. Over the past 10 years, this metric has ranged from a low of 0.24 to a high of 4.97. The Medical Diagnostics & Research industry median Current Ratio is 2.13. China Health Group's value of 2.46 is 15.5% above this industry median. Based on the distribution chart, China Health Group ranks #91 out of 212 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint.
How does China Health Group's Current Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, China Health Group ranks #91 out of 212 companies for Current Ratio. This puts China Health Group in the upper half of its industry. The industry median Current Ratio is 2.13. China Health Group's value of 2.46 is 15.5% above this benchmark. Historically, China Health Group's own Current Ratio has ranged from 0.24 to 4.97 over the past decade. While the company's 10-year median is 2.72 vs. the industry median of 2.13, China Health Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Diagnostics & Research company?
The median Current Ratio among Medical Diagnostics & Research companies is 2.13, based on 212 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Health Group's current Current Ratio of 2.46 is 15.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median Current Ratio is 2.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Health Group's current Current Ratio is 2.46, which is 10% below median its own 10-year median of 2.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Group stock overvalued right now?
Based on GuruFocus' analysis, China Health Group (HKSE:08225) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.21, compared to a current price of HK$0.08 — trading 61.4% below its estimated fair value. The current Current Ratio is 2.46, which is 10% below median its 10-year median of 2.72 and 15.5% above the Medical Diagnostics & Research industry median of 2.13. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For China Health Group (HKSE:08225), the current Current Ratio is 2.46 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
China Health Group Inc is an investment holding company engaged in providing medical care facilities in the People's Republic of China. The company provides provision of post-launch market research, medical and medical market services (PM services), Provision of contracted pharmaceutical development services (PD services), Provision of contracted clinical research services (CR Services), drug technologies, and Other medical services. The majority of its revenue for the company comes from the provision of PM services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08225 has been successfully added to your 
